Are we missing pancreatic exocrine insufficiency in ‘at-risk’ groups? Prospective assessment of the current practice and yield of faecal elastase testing in patients with diabetes mellitus, HIV and/or high alcohol intake
Mustafa Jalal(Royal Bournemouth Hospital), Andrew D. Hopper(Royal Hallamshire Hospital), Solomon Tesfaye(Sheffield Teaching Hospitals NHS Foundation Trust), Hey‐Long Ching(Sheffield Teaching Hospitals NHS Foundation Trust), John Leeds(Newcastle upon Tyne Hospitals NHS Foundation Trust), Andrei I. Oprescu(Sheffield Teaching Hospitals NHS Foundation Trust), A. Tunbridge(Sheffield Teaching Hospitals NHS Foundation Trust), Julia Greig(Sheffield Teaching Hospitals NHS Foundation Trust)
Cited by 4
Related Papers
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations
|Diabetes Research and Clinical Practice|2021|189
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
|The Lancet|2017|186
What Is the Role of Serologic Testing in Celiac Disease? A Prospective, Biopsy-Confirmed Study With Economic Analysis
|Clinical Gastroenterology and Hepatology|2008|182
Methods of investigation for cardiac autonomic dysfunction in human research studies
|Diabetes/Metabolism Research and Reviews|2011|173